NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

MRVI

Maravai LifeSciences Holdings Inc

Jul 03 • 03:07PM ET

2.67

Dollar change +0.02
Percentage change 0.75	%

Healthcare • Biotechnology • USA • NASD

Peers: TMO DHR ILMN BIO RGEN BMRN BIOX ACRS ALDX APLS

| Held by: VTI IWM VB VXF VBK IWN IBB SCHA VTWO VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.15	Insider Own	27.78%	Shs Outstand	143.96M	Perf Week	12.18%
Market Cap	679.94M	Forward P/E	-	EPS next Y	-0.23	Insider Trans	-0.04%	Shs Float	103.47M	Perf Month	20.27%
Enterprise Value	951.20M	PEG	-	EPS next Q	-0.07	Inst Own	77.26%	Short Float	12.61%	Perf Quarter	20.81%
Income	-162.71M	P/S	2.81	EPS this Y	-186.20%	Inst Trans	-6.18%	Short Ratio	6.64	Perf Half Y	-51.54%
Sales	241.86M	P/B	1.28	EPS next Y	20.70%	ROA	-13.53%	Short Interest	13.05M	Perf YTD	-51.01%
Book/sh	2.09	P/C	2.39	EPS next 5Y	-29.53%	ROE	-45.75%	52W High	10.03 -73.38%	Perf Year	-61.53%
Cash/sh	1.12	P/FCF	-	EPS past 3/5Y	- -64.27%	ROIC	-26.20%	52W Low	1.66 60.36%	Perf 3Y	-90.42%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-31.30% 12.61%	Gross Margin	31.11%	Volatility	6.92% 7.04%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.93	EPS Y/Y TTM	-15.82%	Oper. Margin	-34.94%	ATR (14)	0.16	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.17	Sales Y/Y TTM	-11.76%	Profit Margin	-67.28%	RSI (14)	67.17	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.96	EPS Q/Q	-128.70%	SMA20	16.87%	Beta	0.28	Target Price	5.06
Payout	-	Debt/Eq	1.09	Sales Q/Q	-27.00%	SMA50	21.80%	Rel Volume	0.45	Prev Close	2.65
Employees	570	LT Debt/Eq	1.07	Earnings	May 12 AMC	SMA200	-39.44%	Avg Volume	1.97M	Price	2.67
IPO	Nov 20, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-13.15% 5.87%	Trades		Volume	878,186	Change	0.75%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-26-25	Downgrade	Robert W. Baird	Outperform → Neutral	$9 → $3
Dec-19-24	Initiated	Guggenheim	Neutral
Dec-05-24	Downgrade	Goldman	Neutral → Sell	$4.25
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Nov-08-24	Downgrade	William Blair	Outperform → Mkt Perform
Aug-28-24	Initiated	Wells Fargo	Overweight	$10
Aug-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$11 → $10
Apr-10-24	Initiated	Craig Hallum	Buy	$15
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy	$10 → $8
Aug-08-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-23-23	Downgrade	Credit Suisse	Outperform → Neutral	$18 → $14
May-09-23	Downgrade	Goldman	Buy → Neutral
Jan-05-23	Downgrade	UBS	Buy → Neutral	$20 → $16
Dec-14-22	Initiated	Deutsche Bank	Buy	$25
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$22
Nov-03-22	Downgrade	BofA Securities	Buy → Neutral	$32 → $17
Aug-25-22	Initiated	Credit Suisse	Outperform	$34
Aug-05-21	Resumed	Credit Suisse	Outperform	$44
Dec-16-20	Initiated	KeyBanc Capital Markets	Overweight	$33
Dec-15-20	Initiated	William Blair	Outperform

Show Previous Ratings

Jun-25-25 04:01PM	Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer (GlobeNewswire)
Jun-09-25 08:30AM	Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors (GlobeNewswire)
Jun-03-25 10:00AM	TriLink BioTechnologies and Quantoom Biosciences Sign License and Supply Agreement for CleanCap mRNA Capping Technology (Business Wire)
May-21-25 04:22PM	CORRECTION - Maravai LifeSciences Releases 2024 Sustainability Report (GlobeNewswire) -6.25%
04:05PM	Maravai LifeSciences Releases 2024 Sustainability Report (GlobeNewswire)
08:00AM	Loading…
May-20-25 08:00AM	TriLink BioTechnologies debuts its first mRNA synthesis kit with CleanCap capping technology; Celebrates launch with kit donations to top academic institutions (Business Wire) +10.60%
May-14-25 04:00PM	TriLink BioTechnologies and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines (Business Wire)
May-13-25 09:30AM	Q1 2025 Maravai LifeSciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:11AM	Maravai LifeSciences Holdings Inc (MRVI) Q1 2025 Earnings Call Highlights: Navigating Growth ... (GuruFocus.com)
May-12-25 05:20PM	Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +7.07%
04:06PM	Maravai Lifesciences Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-08-25 05:10PM	Jushi Holdings Inc. (JUSHF) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-07-25 07:10PM	MariMed Inc. (MRMD) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-05-25 05:47AM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire)
May-01-25 05:20PM	Stryker (SYK) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:30AM	Loading…
07:30AM	Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025 (GlobeNewswire)
Apr-24-25 12:27PM	Investors in Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Apr-22-25 05:45AM	Investors in Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights - MRVI (PR Newswire) +9.04%
Apr-16-25 06:10PM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations Hagens Berman (GlobeNewswire)
Apr-15-25 09:35AM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire)
Apr-14-25 01:13PM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations Hagens Berman (GlobeNewswire)
Apr-11-25 01:31PM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations Hagens Berman (GlobeNewswire)
Apr-10-25 11:34AM	QuidelOrtho (QDEL) Surges 10.1%: Is This an Indication of Further Gains? (Zacks) -8.25%
04:37AM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations - Hagens Berman (Newsfile)
Apr-04-25 02:34PM	Maravai LifeSciences: Upside Not Likely In 2025, But Company Can Survive (Seeking Alpha) -7.62%
Apr-03-25 06:21PM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire)
Apr-01-25 01:23PM	Shareholders of Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Mar-26-25 11:10AM	Columbia Acorn Fund Q4 2024 Commentary (SeekingAlpha)
Mar-25-25 12:49PM	Is Maravai LifeSciences Holdings, Inc. (MRVI) the Top Stock to Buy According to 12 West Capital Management? (InsiderMonkey)
Mar-24-25 02:33PM	Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
10:30AM	Loading…
Mar-22-25 10:30AM	Maravai Lifesciences price target lowered to $5 from $10 at Stifel (TipRanks)
Mar-21-25 08:00PM	Maravai LifeSciences (MRVI) Q4 2024 Earnings Call Transcript (Motley Fool) -5.62%
01:43PM	Shareholders of Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Mar-20-25 09:00PM	Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2024 Earnings Conference Call Transcript (SeekingAlpha)
Mar-18-25 04:05PM	Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire) -5.81%
05:45AM	Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRVI (PR Newswire)
Mar-17-25 02:22AM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire) +7.76%
Mar-16-25 09:32AM	3 Struggling Stocks Down More Than 50% This Year That Look Cheap But Come With Plenty of Risk (Motley Fool)
Mar-08-25 10:15AM	Maravai LifeSciences Holdings, Inc. (MRVI): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? (Insider Monkey)
Feb-28-25 09:31AM	Maravai LifeSciences Holdings, Inc. (MRVI) Shares Fall 21% After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition - Hagens Berman (PR Newswire) +5.57%
Feb-27-25 06:37PM	Maravai LifeSciences Holdings, Inc. (MRVI) Acquires Officinae Bio to Enhance AI-Driven mRNA Development (Insider Monkey) -6.15%
Feb-25-25 06:00AM	Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call (GlobeNewswire) -21.70%
Feb-24-25 08:00AM	Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio (Business Wire)
Feb-04-25 04:01PM	TriLink BioTechnologies and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA Capping Technology (Business Wire)
Feb-03-25 06:00AM	TriLink BioTechnologies Partners with Avantor to Expand Nucleic Acid Solutions in Europe (Business Wire)
Jan-28-25 04:01PM	Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies (Business Wire) -8.55%
Jan-20-25 11:02PM	Maravai LifeSciences Holdings, Inc. (MRVI) Stock: An Under $5 Gem with Biggest Upside Potential (Insider Monkey)
Jan-08-25 04:10PM	Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue (GlobeNewswire) -20.88%
Dec-20-24 07:15AM	Maravai Lifesciences initiated with a Neutral at Guggenheim (TipRanks)
Dec-05-24 04:05PM	Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors (GlobeNewswire) -6.00%
Nov-12-24 08:05AM	Maravai LifeSciences Announces November 2024 Investor Conference Schedule (GlobeNewswire)
Nov-09-24 06:51AM	Maravai Lifesciences price target lowered to $9 from $10 at Baird (TipRanks)
Nov-08-24 02:20PM	Q3 2024 Maravai LifeSciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents) -35.27%
03:15AM	Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript (Motley Fool)
02:34AM	Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Nov-07-24 04:01PM	Maravai LifeSciences Reports Third Quarter 2024 Financial Results (GlobeNewswire)
04:01PM	Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research (Business Wire)
Oct-15-24 04:05PM	Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024 (GlobeNewswire)
Oct-09-24 08:03AM	RGA Investment Advisors Highlights Maravai LifeSciences Holdings, Inc. (MRVI) in Q1 2024 Letter (Insider Monkey)
Sep-24-24 08:12AM	TriLink BioTechnologies & Alphazyme Collaborate to Launch New CleanScribe RNA Polymerase (Business Wire)
Aug-28-24 07:49AM	Cygnus Technologies and TriLink BioTechnologies Collaborate to Launch AccuRes Host Cell DNA Quantification Kits (Business Wire)
Aug-12-24 08:05AM	Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule (GlobeNewswire)
Aug-08-24 12:45AM	Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript (Motley Fool) -6.87%
Aug-07-24 04:05PM	Maravai LifeSciences Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-29-24 04:05PM	Maravai LifeSciences Appoints Trey Martin to Board of Directors (GlobeNewswire)
Jul-10-24 08:00AM	Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024 (GlobeNewswire)
Jul-02-24 04:00PM	Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report (GlobeNewswire)
Jun-20-24 09:15AM	Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics (ACCESSWIRE)
Jun-17-24 09:54AM	Here's Why RGAIA Considers Maravai LifeSciences Holdings' (MRVI) Margin Structure as the Best (Insider Monkey)
Jun-12-24 02:38AM	Steven Cohen's Strategic Acquisition in Maravai LifeSciences Holdings Inc (GuruFocus.com)
May-17-24 11:52AM	Maravai (MRVI) Advances in RNA Research With New Collaboration (Zacks)
May-13-24 08:00AM	TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center (Business Wire)
May-09-24 04:18PM	Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript (Insider Monkey) +11.16% +6.09%
04:05PM	Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule (GlobeNewswire)
10:53AM	UBS Raises Price Target on Maravai LifeSciences to $8.50 From $6.50, Maintains Neutral Rating (MT Newswires)
10:11AM	Baird Adjusts Price Target on Maravai LifeSciences to $10 From $8, Keeps Outperform Rating (MT Newswires)
04:02AM	Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ... (GuruFocus.com)
03:15AM	Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript (Motley Fool)
May-08-24 08:57PM	MRVI Stock Earnings: Maravai LifeSciences Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	Maravai LifeSciences Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-30-24 07:31AM	TriLink BioTechnologies and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA Capping Technology (Business Wire)
Apr-18-24 07:36AM	TriLink BioTechnologies Announces New San Diego Facility for Late Phase mRNA Drug Substance Production (Business Wire)
Apr-10-24 04:05PM	Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024 (GlobeNewswire)
Mar-28-24 04:00PM	Dyadic Reports 2023 Full Year Results and Recent Company Progress (GlobeNewswire)
Mar-19-24 07:48AM	Should You Sell Maravai LifeSciences (MRVI)? (Insider Monkey)
Mar-12-24 04:15PM	Maravai LifeSciences Announces March 2024 Investor Conference Schedule (GlobeNewswire)
Feb-23-24 12:15PM	Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2023 Earnings Call Transcript (Insider Monkey) +63.60%
10:10AM	Q4 2023 Maravai LifeSciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-22-24 08:30PM	Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript (Motley Fool)
04:43PM	Maravai LifeSciences Holdings Inc (MRVI) Faces Net Loss in 2023 Despite Revenue Outperformance (GuruFocus.com)
04:05PM	Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-21-24 08:00AM	TriLink BioTechnologies Solidifies IP Position with Awarded Patents for CleanCap Capping Technology in China and Canada (Business Wire)
Feb-13-24 08:30AM	Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing (GlobeNewswire) -6.55%
Feb-11-24 05:00PM	3 Doomed Biotech Stocks to Dump Before They Dive: February 2024 (InvestorPlace)
Feb-07-24 06:46AM	Will Maravai LifeSciences Holdings (MRVI) Pipeline Start to Bear Fruit? (Insider Monkey)
Jan-29-24 08:00AM	Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024 (GlobeNewswire)
Dec-18-23 05:27AM	Bank of America Pounds the Table on These 3 Buy-Rated Stocks (TipRanks)
Nov-24-23 08:39AM	Are Options Traders Betting on a Big Move in Maravai LifeSciences (MRVI) Stock? (Zacks)
Nov-09-23 08:15AM	Maravai LifeSciences Announces November 2023 Investor Conference Schedule (GlobeNewswire)
Nov-08-23 04:02PM	Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2023 Earnings Call Transcript (Insider Monkey) -31.69%

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers' research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ORESHACK KURT	General Counsel	Jan 31 '25	Sale	5.03	25,000	125,750	167,618	Jan 31 06:20 PM
ORESHACK KURT	Officer	Jan 31 '25	Proposed Sale	5.03	25,000	125,750		Jan 31 09:42 AM
DeFord John A	Director	Nov 12 '24	Buy	5.75	17,500	100,625	70,046	Nov 14 04:32 PM
HULL CARL	See Remarks	Nov 11 '24	Buy	5.64	175,000	987,000	175,000	Nov 12 04:59 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRVI

Maravai LifeSciences Holdings Inc

Upgrade your FINVIZ experience